6-((3S,4S)-4-Methyl-1-((2-methylpyrimidin-5-yl)methyl)pyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
95%
science Other reagents with same CAS 1082743-82-5
blur_circular Chemical Specifications
description Product Description
This compound is a selective inhibitor of the JAK (Janus kinase) enzyme, particularly JAK1, which plays a crucial role in cytokine signaling pathways involved in inflammation. It is being developed for the treatment of immune system disorders such as rheumatoid arthritis, psoriasis, and other chronic inflammatory conditions.
The mechanism of action of this compound helps reduce abnormal immune responses without completely suppressing the immune system, making it effective in controlling symptoms and reducing the risk of side effects compared to broad-acting drugs.
Due to its unique structure, this compound has good absorption, stability in the body, and can be taken orally, making it suitable for continuous treatment in chronic patients.
Currently, it is in the research and clinical trial stages to confirm safety and efficacy before widespread medical use.
shopping_cart Available Sizes & Pricing
Cart
No products
